Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that sitagliptin will significantly reduce impairments in
insulin secretion and insulin resistance resulting from short-term oral glucocorticoid
therapy.